Clinical Report: The Cannabis Talk That Doesn't Happen
Overview
A study found that fewer than 1 in 5 older adults who used cannabis discussed it with a clinician. Despite an increase in cannabis use among older adults, screening and discussions about cannabis use remain low, highlighting missed opportunities for clinicians.
Background
Cannabis use among older adults has been rising, with 9.5% reporting past-year use in 2023. This trend is significant due to the potential for adverse effects associated with cannabis use in this population, particularly those with chronic conditions. Understanding the barriers to clinician discussions about cannabis is crucial for improving patient care.
Data Highlights
| Statistic | Percentage |
|---|---|
| Older adults reporting past-year cannabis use | 9.5% |
| Older adults screened for drug use | 37% |
| Older adults discussing cannabis with a clinician | 19% |
| Older adults with neither screening nor discussion | 44% |
Key Findings
- Only 19% of older adults who used cannabis discussed it with a clinician.
- 37% reported being screened for drug use, but without discussion.
- Screening was more common among those with multiple chronic conditions.
- Hispanic/Latine older adults were less likely to report screening and discussions compared to White older adults.
- Past-year alcohol use was positively associated with screening but negatively associated with discussions among cannabis users.
- Structural factors like urbanicity and medical cannabis laws did not influence screening or discussions.
Clinical Implications
Clinicians should be aware of the low rates of cannabis discussions with older adults and consider implementing validated screening tools. Attention should be given to disparities in screening and discussions among different racial groups and genders.
Conclusion
The findings indicate a need for enhanced clinician training and support to facilitate discussions about cannabis use among older adults, particularly those at higher risk for adverse effects.
Related Resources & Content
- American Journal of Preventive Medicine, 2023 -- The Cannabis Talk That Doesn't Happen
- The ASCO Post — Another Point of View: Reefer Madness!
- The ASCO Post — Medical Marijuana: The Topic You Can’t Escape
- The ASCO Post — Therapeutic Applications for Cannabinoids in Oncology: The Debate Continues
- Trends in Past-Month Cannabis Use Among Older Adults - PubMed
- Researchers find older adults rarely discuss cannabis use with clinicians
- Older Adults’ Perspectives on and Experiences with Cannabis Use: Results From the 2024 National Poll on Healthy Aging - PMC
- Final Recommendation Statement: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
- Screening for Drug Use in Primary Care: Practical Implications of the New USPSTF Recommendation | Guidelines | JAMA Internal Medicine
- the analytical scientist — Why “Clean” Cannabis May Not Be Clean
- Why “Clean” Cannabis May Not Be Clean
- Medical Marijuana, Recreational Cannabis, and Cardiovascular Health
- Preparing Geriatrics-Trained Physicians to Discuss Medical Cannabis with their Older Adult Patients
- Trends in Past-Month Cannabis Use Among Older Adults - PubMed
- Researchers find older adults rarely discuss cannabis use with clinicians
- Older Adults’ Perspectives on and Experiences with Cannabis Use: Results From the 2024 National Poll on Healthy Aging - PMC
- Final Recommendation Statement: Unhealthy Drug Use: Screening | United States Preventive Services Taskforce
- Screening for Drug Use in Primary Care: Practical Implications of the New USPSTF Recommendation | Guidelines | JAMA Internal Medicine | JAMA Network
- The Effects, Risks and Side Effects of Marijuana (Weed, Cannabis, THC) | SAMHSA
- Cannabis Effective January 28, 2025 TABLE OF CON
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.